{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:35:02Z","timestamp":1784954102100,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.seizure.2021.11.018","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T11:19:56Z","timestamp":1638011996000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Predicting the occurrence of thrombocytopenia from free valproate levels: A prospective study"],"prefix":"10.1016","volume":"94","author":[{"given":"Wassim","family":"Nasreddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir F.","family":"Atweh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan A.","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Dirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Nawfal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.11.018_bib0001","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.48.1.182","article-title":"Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial","volume":"48","author":"Beydoun","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.11.018_bib0002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.1.6003.221-c","article-title":"Sodium valproate and platelet function","volume":"1","author":"Richardson","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.seizure.2021.11.018_bib0003","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1592\/phco.21.17.1325.34418","article-title":"Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital","volume":"21","author":"Conley","year":"2001","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.seizure.2021.11.018_bib0004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/appi.ajp.158.1.128","article-title":"Occurrence of thrombocytopenia in psychiatric patients taking valproate","volume":"158","author":"Trannel","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.seizure.2021.11.018_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.410050414","article-title":"Thrombocytopenia associated with sodium valproate treatment","volume":"5","author":"Neophytides","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2021.11.018_bib0006","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/adc.57.9.681","article-title":"Valproic acid and immune thrombocytopenia","volume":"57","author":"Barr","year":"1982","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.seizure.2021.11.018_bib0007","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","article-title":"Valproate-induced thrombocytopenia: a prospective monotherapy study","volume":"49","author":"Nasreddine","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.11.018_bib0008","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007691-198612000-00005","article-title":"Variable free and total valproic acid concentrations in sole-and multi-drug therapy","volume":"8","author":"Cramer","year":"1986","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.seizure.2021.11.018_bib0009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.seizure.2018.04.012","article-title":"Determinants of free serum valproate concentration: a prospective study in patients on divalproex sodium monotherapy","volume":"59","author":"Nasreddine","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.11.018_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12028-018-0627-4","article-title":"Accuracy of valproic acid concentration correction based on serum albumin","volume":"30","author":"Drisaldi","year":"2019","journal-title":"Neurocritic Care"},{"key":"10.1016\/j.seizure.2021.11.018_bib0011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2146\/ajhp140191","article-title":"Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients","volume":"72","author":"Gibbs","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.seizure.2021.11.018_bib0012","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/phar.1912","article-title":"Valproate protein binding is highly variable in ICU patients and not predicted by total serum concentrations: a case series and literature review","volume":"37","author":"Riker","year":"2017","journal-title":"Pharmacother"},{"key":"10.1016\/j.seizure.2021.11.018_bib0013","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1212\/WNL.42.5.988","article-title":"Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy","volume":"42","author":"Lenn","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.11.018_bib0014","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2021.11.018_bib0015","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.resuscitation.2016.05.027","article-title":"Free serum valproate concentration more reliable than total concentration in critically ill patients","volume":"105","author":"Hatton","year":"2016","journal-title":"Resuscitation"},{"key":"10.1016\/j.seizure.2021.11.018_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","article-title":"Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management","volume":"377","author":"Dasgupta","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.seizure.2021.11.018_bib0017","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/epi.12952","article-title":"Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis","volume":"56","author":"Zighetti","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.11.018_bib0018","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/JCP.0b013e3181db2684","article-title":"Hematological effects of valproate in psychiatric patients: what are the risk factors?","volume":"30","author":"Vasudev","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.seizure.2021.11.018_bib0019","doi-asserted-by":"crossref","first-page":"122","DOI":"10.21315\/mjms2018.25.4.12","article-title":"Sample size guidelines for logistic regression from observational studies with large population: emphasis on the accuracy between statistics and parameters based on real life clinical data","volume":"25","author":"Bujang","year":"2018","journal-title":"Malaysian J Med Sci MJMS"},{"key":"10.1016\/j.seizure.2021.11.018_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238201","article-title":"Safety range of free valproic acid serum concentration in adult patients","volume":"15","author":"Tseng","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.seizure.2021.11.018_bib0021","first-page":"660","article-title":"Assessing thrombocytopenia in the intensive care unit: the past, present, and future","author":"Zarychanski","year":"2017","journal-title":"Hematology 2014, the American Society of Hematology Education Program Book 2017"},{"key":"10.1016\/j.seizure.2021.11.018_bib0022","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcrc.2005.09.008","article-title":"Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors","volume":"20","author":"Crowther","year":"2005","journal-title":"J Crit Care"},{"key":"10.1016\/j.seizure.2021.11.018_bib0023","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate","volume":"22","author":"Acharya","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.seizure.2021.11.018_bib0024","first-page":"113","article-title":"Hemorrhagic diathesis and platelet dysfunction in children under treatment with sodium valproate","volume":"19","author":"Voss","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.11.018_bib0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1528-1157.1999.tb00709.x","article-title":"Valproate treatment and platelet function: the role of arachidonate metabolites","volume":"40","author":"Kis","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.11.018_bib0026","first-page":"135","article-title":"Thrombocytopenia in the intensive care unit patient","author":"Greinacher","year":"2010","journal-title":"Hematology 2010, the American Society of Hematology Education Program Book 2010"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121003769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121003769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:58:43Z","timestamp":1761011923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121003769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":26,"alternative-id":["S1059131121003769"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.11.018","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the occurrence of thrombocytopenia from free valproate levels: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}